Newsroom

September 05, 2018

Celdara Medical, LLC announced today that it has received a three-year, $3.5 million award from the National Institutes of Health (NIH) to support an Institutional Development Award (IDeA) Center of Biomedical Research Excellence. Celdara Medical has been selected to create and operate a Regional Technology Transfer Accelerator Hub in the Northeast (the DRIVEN Accelerator Hub: DE, RI, VT, ME, and NH). This hub will actively collaborate with ten leading research institutions in the Northeast and the other three Hubs in Central, Southeast, and Western regions.

“We are honored to be selected by the NIH to lead this important initiative to improve medical innovation and entrepreneurship in the Northeast,” said Jake Reder, Ph.D., cofounder and CEO of Celdara Medical. “We are eager to start working on this nationally with our affiliate Virtici and with the leaders of the other two regions, along with all of the distinguished institutions participating from DE, RI, VT, ME, NH, and beyond.”

“This is a significant opportunity for small businesses, academia, and the federal government to partner in two critical areas: boosting high-tech innovation and tackling biomedical research needs,” said NIGMS Director Jon R. Lorsch, Ph.D. 

The goal of the DRIVEN Accelerator Hub is to bridge the gap between NIH funded research and improved patient outcomes by increasing the number of medical entrepreneurs and their level of competency. In this vein, the Hub aims to provide the knowledge, skills and training necessary for innovators to become successful entrepreneurs. With the end result of reducing morbidity and mortality nationwide, the program and its initiatives are unique, and have the potential for significant economic and clinical impact.

This award was granted by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number UT2GM130176. The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About Celdara Medical, LLC

Celdara Medical gives hope and health to patients by transforming academic innovations into medicines with the potential to cure the world’s most challenging diseases. Celdara Medical is a recognized leader with a rich stable of discoveries, developed in concert with premiere research institutions in the US, EU, and beyond. We secure lasting partnerships with inventors and their institutions, and provide the developmental, financial, and business acumen to bridge the gaps between discovery and clinical impact. With robust funding options, operations in greater Boston, NYC, and Washington, DC, growing affiliates in Seattle and Indianapolis, a wealth of opportunities in our pipeline, and partnerships with industry leaders worldwide, Celdara Medical navigates the path from science to medicine, accelerating innovation to improve human health.